BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/4/2025 6:30:35 AM | Browse: 10 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 113475
Country India
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease
Manuscript Source Invited Manuscript
All Author List Amal Joseph, Sunil Mathew and Harikumar R Nair
Funding Agency and Grant Number
Corresponding Author Harikumar R Nair, Consultant, FRCP, MRCP, Department of Gastroenterology and Hepatology, Ernakulam Medical Centre, National Highway Bypass, NH 66, Palarivattom, Kochi 682028, Kerala, India. harikumnair@yahoo.co.in
Key Words Metabolic dysfunction-associated steatotic liver disease; Non-alcoholic fatty liver disease; Transient elastography; Fibrosis-4 index; Aspartate transaminase to platelet ratio index; Neutrophil percentage to albumin ratio; Liver stiffness; Steatosis; Fibrosis
Core Tip This study demonstrates that blood-based markers are cost-effective adjuvants to FibroScan for metabolic dysfunction-associated steatotic liver disease (MASLD) assessment. Fibrosis 4 and aspartate transaminase to platelet ratio index demonstrated strong correlations with liver stiffness measurement (LSM), confirming their reliability for fibrosis evaluation. Notably, neutrophil percentage-to-albumin ratio emerged as a novel marker with a specificity (97.67%) for steatosis assessment, while platelet-to-lymphocyte ratio showed an inverse correlation with LSM. These findings support integrating simple blood markers with imaging techniques for enhanced diagnostic precision, particularly valuable in primary care settings where repeated FibroScan measurements are financially or logistically challenging, addressing critical gaps in MASLD management.
Citation Joseph A, Mathew S, Nair HR. Blood markers versus transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; In press
Received
2025-08-27 23:19
Peer-Review Started
2025-08-27 23:20
First Decision by Editorial Office Director
2025-09-03 06:46
Return for Revision
2025-09-03 06:46
Revised
2025-09-16 16:25
Publication Fee Transferred
Second Decision by Editor
2025-12-04 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-04 06:30
Articles in Press
2025-12-04 06:30
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com